Understand the source comparison
Difference Between Epithalon and Pinealon: Mechanism Comparison
Amino Acid Sequence Ala-Glu-Asp-Gly (tetrapeptide) Glu-Asp-Arg (tripeptide) Structurally distinct. Not variations of the same compound Primary Molecular Target hTERT gene promoter in pineal cells (telomerase activation) Neuronal DNA regulatory regions (gene tr
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Amino Acid Sequence
- Ala-Glu-Asp-Gly (tetrapeptide)
- Glu-Asp-Arg (tripeptide)
- Structurally distinct. Not variations of the same compound
- Primary Molecular Target
- hTERT gene promoter in pineal cells (telomerase activation)
- Neuronal DNA regulatory regions (gene transcription modulation)
- Completely separate biochemical pathways
- Primary Tissue Affinity
- Pineal gland, hypothalamus (circadian regulation)
- Hippocampus, cortex, cerebellum (CNS neurons)
- Tissue distribution determines effect profile
- Documented Research Effects
- 33–45% increase in telomerase activity; reduced pineal calcification; restored circadian gene expression
- 28% increase in hippocampal BDNF; elevated acetylcholine receptor density; improved spatial memory in animal models
- Effects are non-overlapping. Select based on research objective
- Typical Research Dosing
- 5–10 mg per 10-day cycle, subcutaneous
- 100–500 mcg per administration, 10–20 day protocols
- Epithalon requires significantly higher absolute dosing
- Primary Research Application
- Cellular aging models, circadian disruption, telomere attrition studies
- Cognitive decline models, neuroplasticity research, neurodegenerative disease protocols
- Choose based on whether the model involves cellular replication or neuronal function